8 completed, 4 unknown, 3 active not recruiting, 2 recruiting. 2 Not applicable, 2 Phase 3, 2 Phase 4, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Unknown 1 |
| Phase 3 | 2 | Active not recruiting 2 |
| Phase 4 | 2 | Completed 1, Recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Viral Hepatitis: new trials by email Literature Review of Viral Hepatitis trials Research Report on Viral Hepatitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Tobevibart+Elebsiran Versus Bulevirtide in Chronic HDV Infection Tobevibart, Elebsiran, Bulevirtide - Viral Hepatitis | Phase 2 | Active not recruiting | Vir Biotechnology, Inc. | 100 | 2025-08-05 | 2026-01-16 |
| A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With Bulevirtide Tobevibart, Elebsiran, Bulevirtide - Viral Hepatitis | Phase 3 | Active not recruiting | Vir Biotechnology, Inc. | 150 | 2025-07-30 | 2026-07-13 |
| Acceptability and Feasibility of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users and Vulnerable Populations, in Non-conventional Structures "Outside the Walls" by Dual Screening Method RTDs and FibroScan® Viral Hepatitis | Recruiting | University Hospital, Limoges | 2300 | 2025-06-05 | 2025-08-14 | |
| A Study to Evaluate Tobevibart + Elebsiran in Chronic HDV Infection Tobevibart, Elebsiran - Viral Hepatitis | Phase 3 | Active not recruiting | Vir Biotechnology, Inc. | 124 | 2025-03-12 | 2026-04-08 |
| VIRal Hepatitis and GAllstone Disease Study Gallstone Attack, Viral Hepatitis | Suspended | Göteborg University | 350 | 2022-10-07 | 2025-04-09 | |
| Prevalence and Clinical Characterization of Hepatitis D Virus (HDV) Infection Among Sudanese Patients With Hepatitis B Virus investigations for Hepatitis D virus - Hepatitis B, Hepatitis D | Completed | National Center for Gastroentestinal and Liver Disease | 90 | 2022-06-01 | 2024-04-11 | |
| Continuing Medical Education to Improve Knowledge of Viral Hepatitis B-C in Primary Healthcare Workers Continuing medical education - Viral Hepatitis | Not applicable | Unknown | Pham Ngoc Thach University of Medicine | 88 | 2022-02-10 | 2022-09-30 |
| A Cost Effective and Time Saving Blood Test to Detect Six Human Bloodborne Infectious Diseases HIV, Viral Hepatitis | Unknown | University Hospital, Montpellier | 500 | 2020-01-01 | 2021-09-14 | |
| Viral Hepatitis B and C Infection in Patients With Idiopathic Thrombocytopenic Purpura Treated With Triple Therapy triple therapy, Steroids - ITP - Immune Thrombocytopenic Purpura, Viral Hepatitis | Unknown | Safaa AA Khaled | 150 | 2019-11-01 | 2019-11-01 | |
| Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B Tenofovir alafenamide, Entecavir - Hepatitis B, Viral Hepatitis | Phase 4 | Recruiting | Taichung Veterans General Hospital | 140 | 2019-08-19 | 2026-05-14 |
| Addressing the Cascade of Care in Vulnerable Populations With Poor Access to Healthcare in Madrid HCV rapid test - HCV Infection, HIV Infections | Completed | Hospital Universitario Infanta Leonor | 2001 | 2019-02-15 | 2021-02-09 | |
| Seroepidemiology of Viral Hepatitis in Hong Kong No intervention - Viral Hepatitis | Completed | Chinese University of Hong Kong | 2888 | 2018-09-01 | 2023-02-08 | |
| Repeatability and Reproducibility of Multiparametric MRI LiverMultiScan - Liver Diseases, Primary Biliary Cirrhosis | Completed | Perspectum | 61 | 2017-06-03 | 2025-12-01 | |
| Non-invasive Biomarkers of Fibrosis in Pediatric Liver Diseases Viral Hepatitis, Liver Fibrosis | Completed | Baylor College of Medicine | 17 | 2013-10-01 | 2018-07-18 | |
| Long-term Follow Up of Viral Hepatitis in Uremic Patients in Taiwan blood sampling - Uremia, Viral Hepatitis | Unknown | Kaohsiung Medical University Chung-Ho Memorial Hospital | 1600 | 2011-01-01 | 2019-03-05 | |
| Prognostic Indicators as Provided by the EPIC ClearView Coronary Artery Disease, Congestive Heart Failure | Completed | Epic Research & Diagnostics, Inc. | 353 | 2010-09-01 | 2011-11-22 | |
| Acoustic Radiation Force Impulse Imaging (ARFI) : a New Technique to Assess Liver Elasticity ARFI measurement - Liver Fibrosis, Liver Cirrhosis | Not applicable | Completed | University Hospital, Bordeaux | 109 | 2010-04-01 | 2026-05-14 |
| Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice. peginterferon plus ribavirin - Hepatitis C Virus, Chronic Liver Disease | Phase 4 | Completed | Azienda Ospedaliera di Padova | 506 | 2005-09-01 | 2010-09-06 |
Hepatitis B (5) · Hepatitis D (4) · Liver Diseases (4) · Digestive System Diseases (3) · Fibrosis (3) · Hepatitis (3) · Hepatitis C (3) · Hepatitis D, Chronic (3) · Heart Failure (2) · Liver Cirrhosis (2) · Acute Kidney Injury (1) · Asthma (1) · Atrial Fibrillation (1) · Bronchitis (1) · Carcinoma, Hepatocellular (1)
Infections (10) · Pathologic Processes (10) · Pathological Conditions, Signs and Symptoms (10) · Digestive System Diseases (9) · Hepatitis, Viral, Human (9) · Virus Diseases (9) · Hepatitis (8) · Liver Diseases (8) · RNA Virus Infections (8) · Blood-Borne Infections (6) · Communicable Diseases (6) · Chronic Disease (5) · DNA Virus Infections (5) · Disease Attributes (5) · Hepadnaviridae Infections (5)
Blood Specimen Collection (2) · bulevirtide (2) · Cyclosporine (1) · Multiparametric Magnetic Resonance Imaging (1) · Physical Examination (1) · Ribavirin (1) · Rituximab (1) · Steroids (1) · entecavir (1) · peginterferon alfa-2a (1) · peginterferon alfa-2b (1) · tenofovir alafenamide (1)
Vir Biotechnology, Inc. (3) · Azienda Ospedaliera di Padova (1) · Baylor College of Medicine (1) · Chinese University of Hong Kong (1) · Epic Research & Diagnostics, Inc. (1) · Göteborg University (1) · Hospital Universitario Infanta Leonor (1) · Kaohsiung Medical University Chung-Ho Memorial Hospital (1) · National Center for Gastroentestinal and Liver Disease (1) · Perspectum (1) · Pham Ngoc Thach University of Medicine (1) · Safaa AA Khaled (1) · Taichung Veterans General Hospital (1) · University Hospital, Bordeaux (1) · University Hospital, Limoges (1)
France (5) · United Kingdom (4) · Germany (3) · Romania (3) · Spain (3) · United States (3) · Italy (2) · Moldova (2) · Netherlands (2) · Pakistan (2) · Taiwan (2) · Ukraine (2) · Austria (1) · Belgium (1) · Bulgaria (1)
Chung-Feng Huang, M.D. (1) · Clair A Francomano, MD (1) · Daniel H Leung, MD (1) · Martin Martin, MD PhD (1) · Mohammad Elyamany, Prof. (1) · Rajarshi Banerjee, BM BCh MS DPhil (1) · Shui Shan Lee, MD (1) · Shymaa Mohamed Nageeb, MD (1) · Teng-Yu Lee, MD, PhD (1)
PMID 41586499, PMID 12611000, PMID 15565615, PMID 16525138, PMID 16879891, PMID 19052126, PMID 19670411, PMID 21349784, PMID 22668640, PMID 22798311, PMID 23732715, PMID 25476749, PMID 26389937, PMID 28404091, PMID 28404092, PMID 28427875, PMID 29405329, PMID 29696665, PMID 33533547, PMID 33753433, PMID 36520162, PMID 757978